Abbott, Merck, Pfizer raising the bar

Share this article:
Abbott Labs stands out as a leader in marketing research, according to a panel discussion at CBI’s 2nd Annual Pharmaceutical Market Research Summit in Philadelphia at the end of April.

“Their business analysts are very personable and you end up with a tight delivery,” said Peter Simpson, president, Segmedica.

 “They are great at integrating information into what they do daily,” added John Tapper, chief strategy officer, Ziment.

Merck was among the large companies given the thumbs-up by the panel. “Merck is a great example of a company getting, and implementing, strategies in the entire space,” said Meredith Abreu, VP at Manhattan Research. “They are very good at getting information out there.”

Pfizer also drew praise. “The brands act like smaller companies,” said Simpson, “so when you go in you are reporting it your way.”

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...